INS and type 1 diabetes mellitus: Studies have indicated that bone marrow mesenchymal stem cells (BMSCs) (6) and embryonic stem cells (ESCs) (7) can differentiate into insulin-producing cells and can used in transplantion therapy for type 1 diabetes.